Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Theravance, Inc.”

369 pharma patents match "Theravance, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 369
Index total 30,257
Page 4 / 16

Quick answer

This filtered view shows 369 pharmaceutical patents matching "Theravance, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

369 results for “Theravance, Inc.” · 30,257 patents in full index Clear search

  1. US 8314128

    Aminotetralin compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Nov 20, 2012 · Expires Nov 15, 2032

    granted

  2. US 8314217

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Nov 20, 2012 · Expires Nov 15, 2032

    granted

  3. US 8304433

    Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound

    Theravance, Inc. · Granted Nov 6, 2012 · Expires Nov 1, 2032

    granted

  4. US 8304432

    4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds

    Theravance, Inc. · Granted Nov 6, 2012 · Expires Nov 1, 2032

    granted

  5. US 8288550

    Crystalline form of a benzimidazole-carboxamide medicinal compound

    Theravance, Inc. · Granted Oct 16, 2012 · Expires Oct 11, 2032

    granted

  6. US 8273786

    3-phenoxymethylpyrrolidine compounds

    Theravance, Inc. · Granted Sep 25, 2012 · Expires Sep 20, 2032

    granted

  7. US 8273894

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Sep 25, 2012 · Expires Sep 20, 2032

    granted

  8. US 8268863

    Disubstituted alkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted

  9. US 8263618

    8-azabicyclo[3.2.1]octane compounds as MU opioid receptor antagonists

    Theravance, Inc. · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted

  10. US 8247555

    Crystalline forms of an 8-azabicyclo[3.2.1]octane compound

    Theravance, Inc. · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted

  11. US 8247433

    Process for preparing 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds

    Theravance, Inc. · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted

  12. US 8247564

    Compounds having BETA2 adrenergic receptor agonist and muscarinic receptor antagonist activity

    Theravance, Inc. · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted

  13. US 8242137

    Crystalline forms of a biphenyl compound

    Theravance, Inc. · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted

  14. US 8242135

    Biphenyl derivatives

    Theravance, Inc. · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted

  15. US 8242138

    Amidine-containing compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted

  16. US 8242164

    3-(phenoxyphenylmethyl)pyrrolidine compounds

    Theravance, Inc. · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted

  17. US 8236839

    Dual-acting antihypertensive agents

    Theravance, Inc. · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted

  18. US 8236846

    Dual-acting antihypertensive agents

    Theravance, Inc. · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted

  19. US 8227497

    Dual-acting antihypertensive agents

    Theravance, Inc. · Granted Jul 24, 2012 · Expires Jul 19, 2032

    granted

  20. US 8211915

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted

  21. US 8212052

    Dual-acting benzoimidazole antihypertensive agents

    Theravance, Inc. · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted

  22. US 8211894

    Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted

  23. US 8202891

    Quaternary ammonium compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Jun 19, 2012 · Expires Jun 14, 2032

    granted

  24. US 8198304

    Guanidine-containing compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Jun 12, 2012 · Expires Jun 7, 2032

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.